Prof Anindita Roy, Associate Professor in the Department of Paediatrics, has been awarded a Wellcome Clinical Research Career Development Fellowship to study the developmentally-regulated changes in haematopoiesis that lead to treatment-resistant childhood leukaemias. The project will specifically focus on infant Acute Lymphoblastic Leukaemia (iALL), a type of cancer with high relapse rates and poor survival. These types of cancer are characterised by a translocation in the MLL gene, which takes place in utero. Prof Roy will examine at the molecular level why human fetal cells are particularly susceptible to this type of leukaemic transformation and how it progresses, using both in vitro and in vivo models. The ultimate aim of the research is to develop new and effective treatments for this condition.
Many congratulations to Prof Andi Roy who was awarded a fellowship to further develop her independent research.
